Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 267

1.

Relation between invasive hemodynamics and measured glomerular filtration rate by 51Cr-EDTA clearance in advanced heart failure.

Deis T, Balling L, Boesgaard S, Rossing K, Schou M, Oturai P, Wolsk E, Gustafsson F.

Scand J Clin Lab Invest. 2019 Feb 20:1-8. doi: 10.1080/00365513.2019.1576221. [Epub ahead of print]

PMID:
30784338
2.

Lung diffusion capacity in advanced heart failure: relation to central haemodynamics and outcome.

Deis T, Balling L, Rossing K, Wolsk E, Perch M, Gustafsson F.

ESC Heart Fail. 2019 Feb 19. doi: 10.1002/ehf2.12401. [Epub ahead of print]

PMID:
30784223
3.

Continuous-Flow LVADs in the Nordic Countries: Complications and Mortality and its Predictors.

Braun OÖ, Nilsson J, Gustafsson F, Dellgren G, Fiane AE, Lemström K, Hubbert L, Hellgren L, Lund LH.

Scand Cardiovasc J. 2019 Feb 19:1-22. doi: 10.1080/14017431.2019.1583365. [Epub ahead of print]

PMID:
30776923
4.

Effect of High-Intensity Interval Training in De Novo Heart Transplant Recipients in Scandinavia: 1-Year Follow-Up of the HITTS Randomized, Controlled Study.

Nytrøen K, Rolid K, Andreassen AK, Yardley M, Gude E, Dahle DO, Bjørkelund E, Authen AR, Grov I, Wigh JP, Dall CH, Gustafsson F, Karason K, Gullestad L.

Circulation. 2019 Feb 18. doi: 10.1161/CIRCULATIONAHA.118.036747. [Epub ahead of print]

PMID:
30773030
5.

Effect of Heart Rate Reserve on Exercise Capacity in Patients Treated with a Continuous Left Ventricular Assist Device.

Mirza KK, Cuomo K, Jung MH, Russell SD, Gustafsson F.

ASAIO J. 2019 Jan 24. doi: 10.1097/MAT.0000000000000955. [Epub ahead of print]

PMID:
30688691
6.

The Potential Role of Transcatheter Heart Valve Interventions in Heart Failure Treatment.

Søndergaard L, Gustafsson F.

JACC Cardiovasc Interv. 2019 Jan 28;12(2):166-168. doi: 10.1016/j.jcin.2018.11.003. Epub 2018 Dec 26. No abstract available.

PMID:
30594512
7.

Repetitive levosimendan treatment in the management of advanced heart failure.

Oliva F, Comin-Colet J, Fedele F, Fruhwald F, Gustafsson F, Kivikko M, Borbély A, Pölzl G, Tschöpe C.

Eur Heart J Suppl. 2018 Dec;20(Suppl I):I11-I20. doi: 10.1093/eurheartj/suy040. Epub 2018 Nov 2.

8.

Computed Tomography-Estimated Right Ventricular Function and Exercise Capacity in Patients with Continuous-Flow Left Ventricular Assist Devices.

Mirza KK, Jung MH, Sigvardsen PE, Kofoed KF, Elming MB, Rossing K, Gustafsson F.

ASAIO J. 2018 Nov 27. doi: 10.1097/MAT.0000000000000925. [Epub ahead of print]

PMID:
30489293
9.

Right Ventricular and Pulmonary Vascular Function are Influenced by Age and Volume Expansion in Healthy Humans.

Wolsk E, Bakkestrøm R, Kristensen CB, Aagaard Myhr K, Thomsen JH, Balling L, Andersen MJ, Dahl JS, Shah SJ, Gustafsson F, Hassager C, Møller JE.

J Card Fail. 2019 Jan;25(1):51-59. doi: 10.1016/j.cardfail.2018.11.013. Epub 2018 Nov 22.

PMID:
30472282
10.

Levosimendan in Acute and Advanced Heart Failure: an Expert Perspective on Posology and Therapeutic Application.

Bouchez S, Fedele F, Giannakoulas G, Gustafsson F, Harjola VP, Karason K, Kivikko M, von Lewinski D, Oliva F, Papp Z, Parissis J, Pollesello P, Pölzl G, Tschöpe C.

Cardiovasc Drugs Ther. 2018 Dec;32(6):617-624. doi: 10.1007/s10557-018-6838-2. Review.

11.

Repetitive levosimendan infusions for patients with advanced chronic heart failure in the vulnerable post-discharge period.

Pölzl G, Allipour Birgani S, Comín-Colet J, Delgado JF, Fedele F, García-Gonzáles MJ, Gustafsson F, Masip J, Papp Z, Störk S, Ulmer H, Vrtovec B, Wikström G, Altenberger J.

ESC Heart Fail. 2019 Feb;6(1):174-181. doi: 10.1002/ehf2.12366. Epub 2018 Oct 30.

12.

Long-Term Cardiac Function After Peripartum Cardiomyopathy and Preeclampsia: A Danish Nationwide, Clinical Follow-Up Study Using Maximal Exercise Testing and Cardiac Magnetic Resonance Imaging.

Ersbøll AS, Bojer AS, Hauge MG, Johansen M, Damm P, Gustafsson F, Vejlstrup NG.

J Am Heart Assoc. 2018 Oct 16;7(20):e008991. doi: 10.1161/JAHA.118.008991.

13.

Pulmonary Arterial Wedge Pressure at Rest and During Exercise in Healthy Adults: A Systematic Review and Meta-analysis.

Esfandiari S, Wolsk E, Granton D, Azevedo L, Valle FH, Gustafsson F, Mak S.

J Card Fail. 2019 Feb;25(2):114-122. doi: 10.1016/j.cardfail.2018.10.009. Epub 2018 Oct 23.

PMID:
30366054
14.

Impact of Baseline Hemodynamics on the Effects of a Transcatheter Interatrial Shunt Device in Heart Failure With Preserved Ejection Fraction.

Wessler J, Kaye D, Gustafsson F, Petrie MC, Hasenfuβ G, Lam CSP, Borlaug BA, Komtebedde J, Feldman T, Shah SJ, Burkhoff D; REDUCE-LAP-HF Trial Investigators and Advisors.

Circ Heart Fail. 2018 Aug;11(8):e004540. doi: 10.1161/CIRCHEARTFAILURE.117.004540.

PMID:
30354556
15.

Effect of Everolimus Initiation and Calcineurin Inhibitor Elimination on Cardiac Allograft Vasculopathy in De Novo Heart Transplant Recipients.

Arora S, Andreassen AK, Karason K, Gustafsson F, Eiskjær H, Bøtker HE, Rådegran G, Gude E, Ioanes D, Solbu D, Dellgren G, Ueland T, Aukrust P, Gullestad L; SCHEDULE (Scandinavian Heart Transplant Everolimus De Novo Study With Early Calcineurin Inhibitors Avoidance) Investigators.

Circ Heart Fail. 2018 Sep;11(9):e004050. doi: 10.1161/CIRCHEARTFAILURE.117.004050.

PMID:
30354362
16.

Impact of an interatrial shunt device on survival and heart failure hospitalization in patients with preserved ejection fraction.

Kaye DM, Petrie MC, McKenzie S, Hasenfuβ G, Malek F, Post M, Doughty RN, Trochu JN, Gustafsson F, Lang I, Kolodziej A, Westenfeld R, Penicka M, Rosenberg M, Hausleiter J, Raake P, Jondeau G, Bergmann MW, Spelman T, Aytug H, Ponikowski P, Hayward C; REDUCE LAP-HF study investigators.

ESC Heart Fail. 2019 Feb;6(1):62-69. doi: 10.1002/ehf2.12350. Epub 2018 Oct 11.

17.

Postmarket Experience With HeartMate 3 Left Ventricular Assist Device: 30-Day Outcomes From the ELEVATE Registry.

Garbade J, Gustafsson F, Shaw S, Lavee J, Saeed D, Pya Y, Krabatsch T, Schmitto JD, Morshuis M, Chuang J, Zimpfer D.

Ann Thorac Surg. 2019 Jan;107(1):33-39. doi: 10.1016/j.athoracsur.2018.07.092. Epub 2018 Oct 3.

PMID:
30291831
18.

Clinical features and determinants of VO2peak in de novo heart transplant recipients.

Rolid K, Andreassen AK, Yardley M, Bjørkelund E, Karason K, Wigh JP, Dall CH, Gustafsson F, Gullestad L, Nytrøen K.

World J Transplant. 2018 Sep 10;8(5):188-197. doi: 10.5500/wjt.v8.i5.188.

19.

Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.

Gustafsson F, Shaw S, Lavee J, Saeed D, Pya Y, Krabatsch T, Schmitto J, Morshuis M, Chuang J, Damme L, Zimpfer D, Garbade J.

Eur Heart J. 2018 Oct 1;39(37):3454-3460. doi: 10.1093/eurheartj/ehy513.

PMID:
30165521
20.

Impact of CMV PCR Blips in Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Lodding IP, Mocroft A, da Cunha Bang C, Gustafsson F, Iversen M, Kirkby N, Perch M, Rasmussen A, Sengeløv H, Sørensen SS, Lundgren JD.

Transplant Direct. 2018 May 16;4(6):e355. doi: 10.1097/TXD.0000000000000787. eCollection 2018 Jun.

21.

Cardiac procholecystokinin expression during haemodynamic changes in the mammalian heart.

Goetze JP, Hunter I, Zois NE, Terzic D, Valeur N, Olsen LH, Smith J, Plomgaard P, Hansen LH, Rehfeld JF, Balling L, Gustafsson F.

Peptides. 2018 Oct;108:7-13. doi: 10.1016/j.peptides.2018.08.004. Epub 2018 Aug 16.

PMID:
30121362
22.

Copeptin levels and invasive hemodynamics in patients with advanced heart failure.

Balling L, Goetze JP, Jung MH, Rossing K, Boesgaard S, Gustafsson F.

Biomark Med. 2018 Aug;12(8):861-870. doi: 10.2217/bmm-2017-0439. Epub 2018 Jul 30.

PMID:
30058349
23.

Hemodynamic effects of short-term infusion of a vasopressin V1A/V2 receptor antagonist conivaptan in patients withchronic heart failure during submaximal exercise.

Balling L, Thomsen JH, Wolsk E, Hassager C, Boesgaard S, Goldsmith SR, Gustafsson F.

Am Heart J. 2018 Sep;203:101-104. doi: 10.1016/j.ahj.2018.05.015. Epub 2018 Jun 14. No abstract available.

PMID:
30057012
24.

Classification of death causes after transplantation (CLASS): Evaluation of methodology and initial results.

Wareham NE, Da Cunha-Bang C, Borges ÁH, Ekenberg C, Gerstoft J, Gustafsson F, Hansen D, Heilmann C, Helleberg M, Hillingsø J, Krohn PS, Lodding IP, Lund TK, Lundgren L, Mocroft A, Perch M, Petersen SL, Petruskevicius I, Rasmussen A, Rossing K, Rostved AA, Sengeløv H, Sørensen VR, Sørensen SS, Lundgren JD.

Medicine (Baltimore). 2018 Jul;97(29):e11564. doi: 10.1097/MD.0000000000011564.

25.

Bromocriptine for the treatment of peripartum cardiomyopathy: comparison of outcome with a Danish cohort.

Ersbøll AS, Arany Z, Gustafsson F.

Eur Heart J. 2018 Oct 1;39(37):3476-3477. doi: 10.1093/eurheartj/ehy405. No abstract available.

PMID:
30016425
26.

Cardiac systolic dysfunction in past illicit users of anabolic androgenic steroids.

Rasmussen JJ, Schou M, Madsen PL, Selmer C, Johansen ML, Ulriksen PS, Dreyer T, Kümler T, Plesner LL, Faber J, Gustafsson F, Kistorp C.

Am Heart J. 2018 Sep;203:49-56. doi: 10.1016/j.ahj.2018.06.010. Epub 2018 Jun 27.

PMID:
30015068
27.

Cytomegalovirus (CMV) Disease Despite Weekly Preemptive CMV Strategy for Recipients of Solid Organ and Hematopoietic Stem Cell Transplantation.

Lodding IP, da Cunha Bang C, Sørensen SS, Gustafsson F, Iversen M, Kirkby N, Perch M, Rasmussen A, Sengeløv H, Mocroft A, Lundgren JD.

Open Forum Infect Dis. 2018 Apr 17;5(5):ofy080. doi: 10.1093/ofid/ofy080. eCollection 2018 May.

28.

Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology.

Crespo-Leiro MG, Metra M, Lund LH, Milicic D, Costanzo MR, Filippatos G, Gustafsson F, Tsui S, Barge-Caballero E, De Jonge N, Frigerio M, Hamdan R, Hasin T, Hülsmann M, Nalbantgil S, Potena L, Bauersachs J, Gkouziouta A, Ruhparwar A, Ristic AD, Straburzynska-Migaj E, McDonagh T, Seferovic P, Ruschitzka F.

Eur J Heart Fail. 2018 Nov;20(11):1505-1535. doi: 10.1002/ejhf.1236. Epub 2018 Jul 17.

PMID:
29806100
29.

The value of EBV DNA in early detection of post-transplant lymphoproliferative disorders among solid organ and hematopoietic stem cell transplant recipients.

Wareham NE, Mocroft A, Sengeløv H, Da Cunha-Bang C, Gustafsson F, Heilmann C, Iversen M, Kirkby NS, Rasmussen A, Sørensen SS, Lundgren JD; MATCH in PERSIMUNE study group.

J Cancer Res Clin Oncol. 2018 Aug;144(8):1569-1580. doi: 10.1007/s00432-018-2674-9. Epub 2018 May 26.

PMID:
29804164
30.

When the VEST Does Not Fit: Representations of Trial Results Deviating From Rigorous Data Interpretation.

Allen LA, Adler ED, Bayés-Genis A, Brisco-Bacik MA, Chirinos JA, Claggett B, Cook JL, Fang JC, Gustafsson F, Ho CY, Kapur NK, Klewer SE, Kociol RD, Lanfear DE, Vardeny O, Sweitzer NK.

Circ Heart Fail. 2018 Apr;11(4):e005116. doi: 10.1161/CIRCHEARTFAILURE.118.005116. No abstract available.

PMID:
29666074
31.
32.

Psychological adaptation after peripartum cardiomyopathy: A qualitative study.

de Wolff M, Ersbøll AS, Hegaard H, Johansen M, Gustafsson F, Damm P, Midtgaard J.

Midwifery. 2018 Jul;62:52-60. doi: 10.1016/j.midw.2018.03.012. Epub 2018 Mar 27.

PMID:
29655005
33.

Clinical presentation, management and prognosis of patients with cardiac sarcoidosis.

Ghanizada M, Rossing K, Bundgaard H, Gustafsson F.

Dan Med J. 2018 Apr;65(4). pii: A5462.

PMID:
29619923
34.

Sound analysis of a left ventricular assist device: A technical evaluation of iOS devices.

Sundbom P, Roth M, Granfeldt H, Karlsson DM, Ahn H, Gustafsson F, Hubbert L.

Int J Artif Organs. 2018 May;41(5):254-260. doi: 10.1177/0391398818762352. Epub 2018 Mar 9.

PMID:
29519192
35.

Authors' reply re: Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.

Guldbrandt Hauge M, Johansen M, Vejlstrup N, Gustafsson F, Damm P, Ersbøll AS.

BJOG. 2018 Jul;125(8):1040-1041. doi: 10.1111/1471-0528.15143. Epub 2018 Feb 26. No abstract available.

PMID:
29479809
36.

Low-Dose Aspirin in Heart Failure Not Complicated by Atrial Fibrillation: A Nationwide Propensity-Matched Study.

Madelaire C, Gislason G, Kristensen SL, Fosbøl EL, Bjerre J, D'Souza M, Gustafsson F, Kober L, Torp-Pedersen C, Schou M.

JACC Heart Fail. 2018 Feb;6(2):156-167. doi: 10.1016/j.jchf.2017.09.021.

37.

Layer-specific deformation analysis in severe aortic valve stenosis, primary mitral valve regurgitation, and healthy individuals validated against invasive hemodynamic measurements of heart function.

Bakkestrøm R, Christensen NL, Wolsk E, Banke A, Dahl JS, Andersen MJ, Gustafsson F, Hassager C, Møller JE.

Echocardiography. 2018 Feb;35(2):170-178. doi: 10.1111/echo.13747. Epub 2018 Jan 21.

PMID:
29356100
38.

The inodilator levosimendan as a treatment for acute heart failure in various settings.

Gustafsson F, Guarracino F, Schwinger RHG.

Eur Heart J Suppl. 2017 Mar;19(Suppl C):C2-C7. doi: 10.1093/eurheartj/sux001. Epub 2017 Mar 8.

39.

Heart transplantation turns 50 and is going strong.

Crespo-Leiro MG, Gustafsson F.

Eur J Heart Fail. 2017 Dec;19(12):1564-1565. doi: 10.1002/ejhf.1096. Epub 2017 Dec 7. No abstract available.

40.

Subsequent reproductive outcome among women with peripartum cardiomyopathy: a nationwide study.

Guldbrandt Hauge M, Johansen M, Vejlstrup N, Gustafsson F, Damm P, Ersbøll AS.

BJOG. 2018 Jul;125(8):1018-1025. doi: 10.1111/1471-0528.15046. Epub 2017 Dec 10.

PMID:
29211333
41.

Medical and mechanical unloading in advanced heart failure: hope for cardiac recovery?

Rossing K, Gustafsson F.

Eur J Heart Fail. 2018 Jan;20(1):175-177. doi: 10.1002/ejhf.1081. Epub 2017 Nov 21. No abstract available.

42.

Influence of renal impairment on aldosterone status, calcium metabolism, and vasopressin activity in outpatients with systolic heart failure.

Bosselmann H, Tonder N, Sölétormos G, Gaborit F, Rossing K, Iversen K, Goetze JP, Gustafsson F, Schou M.

ESC Heart Fail. 2017 Nov;4(4):554-562. doi: 10.1002/ehf2.12186. Epub 2017 Jul 11.

43.

Heart transplantation in arrhythmogenic right ventricular cardiomyopathy - Experience from the Nordic ARVC Registry.

Gilljam T, Haugaa KH, Jensen HK, Svensson A, Bundgaard H, Hansen J, Dellgren G, Gustafsson F, Eiskjær H, Andreassen AK, Sjögren J, Edvardsen T, Holst AG, Svendsen JH, Platonov PG.

Int J Cardiol. 2018 Jan 1;250:201-206. doi: 10.1016/j.ijcard.2017.10.076. Epub 2017 Oct 21.

PMID:
29107359
44.

Longitudinal shortening of sub-epicardial myocytes in severe ischaemic cardiomyopathy: insights from gadolinium contrast cardiac magnetic resonance imaging.

Bjerre J, Kyhl K, Gustafsson F, Kelbaek H, Engstrøm T, Olsen PS, Hasbak P, Vejlstrup N, Madsen PL.

ESC Heart Fail. 2017 Nov;4(4):670-674. doi: 10.1002/ehf2.12187. Epub 2017 Oct 13.

45.

The European Registry for Patients with Mechanical Circulatory Support (EUROMACS) of the European Association for Cardio-Thoracic Surgery (EACTS): second report.

de By TMMH, Mohacsi P, Gahl B, Zittermann A, Krabatsch T, Gustafsson F, Leprince P, Meyns B, Netuka I, Caliskan K, Castedo E, Musumeci F, Vincentelli A, Hetzer R, Gummert J; EUROMACS members.

Eur J Cardiothorac Surg. 2017 Sep 29. doi: 10.1093/ejcts/ezx320. [Epub ahead of print]

PMID:
29029117
46.

Impact of atrial fibrillation on rest and exercise haemodynamics in heart failure with mid-range and preserved ejection fraction.

Kaye DM, Silvestry FE, Gustafsson F, Cleland JG, van Veldhuisen DJ, Ponikowski P, Komtebedde J, Nanayakkara S, Burkhoff D, Shah SJ.

Eur J Heart Fail. 2017 Dec;19(12):1690-1697. doi: 10.1002/ejhf.930. Epub 2017 Oct 11.

47.

Management of patients with cardiogenic shock on temporary mechanical circulatory support: urgent transplantation or on to the next pump?

Gustafsson F.

Eur J Heart Fail. 2018 Jan;20(1):187-189. doi: 10.1002/ejhf.1023. Epub 2017 Oct 6. No abstract available.

48.

Screening for heart transplantation and left ventricular assist system: results from the ScrEEning for advanced Heart Failure treatment (SEE-HF) study.

Lund LH, Trochu JN, Meyns B, Caliskan K, Shaw S, Schmitto JD, Schibilsky D, Damme L, Heatley J, Gustafsson F.

Eur J Heart Fail. 2018 Jan;20(1):152-160. doi: 10.1002/ejhf.975. Epub 2017 Sep 27.

49.

Resting and exercise haemodynamics in relation to six-minute walk test in patients with heart failure and preserved ejection fraction.

Wolsk E, Kaye D, Borlaug BA, Burkhoff D, Kitzman DW, Komtebedde J, Lam CSP, Ponikowski P, Shah SJ, Gustafsson F.

Eur J Heart Fail. 2018 Apr;20(4):715-722. doi: 10.1002/ejhf.976. Epub 2017 Sep 26.

PMID:
28949052
50.

Age and Outcomes of Primary Prevention Implantable Cardioverter-Defibrillators in Patients With Nonischemic Systolic Heart Failure.

Elming MB, Nielsen JC, Haarbo J, Videbæk L, Korup E, Signorovitch J, Olesen LL, Hildebrandt P, Steffensen FH, Bruun NE, Eiskjær H, Brandes A, Thøgersen AM, Gustafsson F, Egstrup K, Videbæk R, Hassager C, Svendsen JH, Høfsten DE, Torp-Pedersen C, Pehrson S, Køber L, Thune JJ.

Circulation. 2017 Nov 7;136(19):1772-1780. doi: 10.1161/CIRCULATIONAHA.117.028829. Epub 2017 Sep 6.

PMID:
28877914

Supplemental Content

Loading ...
Support Center